Nancy Anderson is a Dermatology physician affiliated with Loma Linda University. OpenAlex indexes 56 publications with 1,127 citations (h-index 18).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
11370 Anderson St
Ste 2600
Loma Linda, CA 923543450
Telephone
909-558-2055Registry record last updated 8 Jul 2007.
Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year202519 payments$23,792openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year20256 payments
- Verrica Pharmaceuticals Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
43.4%Azole Antifungal31%Ketoconazole100%Part D≥99 patientsNitroimidazole Antimicrobial4.6%Metronidazole100%Part D≥21 patients+ 3 more classes in this area
Dermatology
18.8%Corticosteroid15.7%Triamcinolone Acetonide71%Triamcinolone acetonide29%Part D + Part B≥49 patientsOther antifungals for topical use3.1%Ciclopirox100%Part D≥11 patientsCancer & immunology
18.8%Porphyrin Precursor6.6%Aminolevulinic acid hcl100%Part B, office-administered≥38 patientsNucleoside Metabolic Inhibitor5%Fluorouracil100%Part D≥31 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2004–2008 per NIH RePORTER. The latest:
- Core--Participatory Research and Community Partnerships
University of California Los Angeles
FY2008$150,912P30NR005041 - Core--Participatory Research and Community Partnerships
University of California Los Angeles
FY2007$149,331P30NR005041
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Latika Puri, MD
Loma Linda University
Gary Fraser, MD
Loma Linda University
Feng Yan
Loma Linda University
Reinhard Schulte, MD
Loma Linda University
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”